- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Wilmington Savings Fund Society FSB Reduces Bristol Myers Squibb Holdings
The fund decreased its stake in the biopharmaceutical company by 20.8% in the third quarter.
Mar. 19, 2026 at 11:33am
Got story updates? Submit your updates here. ›
Wilmington Savings Fund Society FSB, a financial institution, decreased its holdings in shares of Bristol Myers Squibb Company by 20.8% during the 3rd quarter, according to the company's recent Form 13F filing with the Securities and Exchange Commission. The fund owned 116,259 shares of the biopharmaceutical company's stock, valued at $5,243,000 as of the filing.
Why it matters
This filing provides insight into the investment decisions and portfolio changes of Wilmington Savings Fund Society FSB, which could be indicative of broader market trends or shifts in sentiment around Bristol Myers Squibb's stock.
The details
Wilmington Savings Fund Society FSB sold 30,571 shares of Bristol Myers Squibb during the third quarter, reducing its total holdings in the company to 116,259 shares. The fund's position in Bristol Myers Squibb was valued at $5,243,000 as of the most recent SEC filing.
- The filing covers the 3rd quarter of the year.
- Wilmington Savings Fund Society FSB owned 116,259 shares of Bristol Myers Squibb as of the most recent SEC filing.
The players
Wilmington Savings Fund Society FSB
A financial institution that decreased its holdings in Bristol Myers Squibb Company by 20.8% during the 3rd quarter.
Bristol Myers Squibb Company
A biopharmaceutical company whose stock is held by Wilmington Savings Fund Society FSB.
The takeaway
This filing highlights the investment decisions of Wilmington Savings Fund Society FSB, which reduced its position in Bristol Myers Squibb during the third quarter. This could signal broader market trends or shifts in sentiment around the biopharmaceutical company's stock.
